Determining the role of CD44 in CRC stemness and tumorigenicity thus remains challenging due to the potential co-expression of splice variants and functionally distinct isoforms 9 as well as the putative environmentally and/or epigenetically driven marker plasticity. The gene discussed is CD44; the disease is colorectal carcinoma.